Taipei, Taiwan

Lu-Ping Lu

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Profile: Lu-Ping Lu

Introduction

Lu-Ping Lu is a notable inventor based in New Taipei, Taiwan. With a total of four patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic uses.

Latest Patents

Lu's most recent patents include innovative compounds and their pharmaceutical applications. One of the key patents describes a compound of Formula (I) or a pharmaceutically acceptable salt thereof, where Ring X is a 3 to 7 membered monocyclic ring. This patent details compounds wherein at least one of the substituents (R, R, R, and R) is OH, OR, CHOR, or a halogen. Additionally, his research includes a method for treating coronavirus infection through the administration of a composition that comprises one or more compounds of Formula (I).

Career Highlights

Lu-Ping Lu currently works at Syneurx International (Taiwan) Corp., a company that focuses on innovative pharmaceutical research and development. His dedication and expertise have fostered advancements in treating various viral infections, showcasing his impact on public health.

Collaborations

Throughout his career, Lu has collaborated with notable colleagues including Guochuan Emil Tsai and Yi-Wen Mao. Working alongside these talented individuals has enabled him to enhance his research and contribute significantly to their projects, driving innovative solutions in the pharmaceutical industry.

Conclusion

Lu-Ping Lu's contributions to the field of pharmaceuticals underscore the importance of innovation in addressing public health issues. With his impactful patents and productive collaborations, he continues to be a prominent figure in the realm of inventors, paving the way for future advancements and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…